Drug-induced changes of striatal cholinergic and dopaminergic functions in rats with spreading depression.
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001115:Arecoline / Q000494:pharmacology; D001285:Atropine / Q000494:pharmacology; D001479:Basal Ganglia / Q000378:metabolism*; D001545:Benserazide / Q000494:pharmacology; D003342:Corpus Striatum / Q000378:metabolism; D013181:Cortical Spreading Depression / Q000187:drug effects*; D004295:Dihydroxyphenylalanine / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D018492:Dopamine Antagonists; D008297:Male; D009538:Nicotine / Q000494:pharmacology; D010095:Oxotremorine / Q000494:pharmacology; D010275:Parasympathetic Nervous System / Q000378:metabolism*; D010293:Pargyline / Q000494:pharmacology; D011189:Potassium Chloride / Q000378:metabolism; D011807:Quinolizines / Q000494:pharmacology; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects; D013997:Time Factors
D018492:Dopamine Antagonists; D011807:Quinolizines; D011955:Receptors, Drug; D001115:Arecoline; D010095:Oxotremorine; D004295:Dihydroxyphenylalanine; D011189:Potassium Chloride; D009538:Nicotine; D001545:Benserazide; D001285:Atropine; D010293:Pargyline; D001058:Apomorphine; D000109:Acetylcholine; D004298:Dopamine